Serial Number
90798006
Owner
EmendoBio Inc.Attorney
LAUREN GREGORY LEIPOLDFiling Date
Jun 28, 2021
EMENDOBIO Trademark
Serial Number: 90798006
Trademark Classes
Class 1 - Chemicals
Chemical products for industry, science, photography, agriculture, horticulture and forestry
Class 5 - Pharmaceuticals
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Class 42 - Computer & Scientific
Scientific and technological services; industrial analysis and research services
Owner Contact Info
Legal Representation
Correspondence Address
LAUREN GREGORY LEIPOLD SEYFARTH SHAW LLP
1075 PEACHTREE STREET, NE
SUITE 2500
ATLANTA, GA 30309
United States
Trademark Details
Filing Date
June 28, 2021
Registration Date
Not Registered
Published for Opposition
December 27, 2022
Goods & Services
Enzymes for scientific and research purposes; nucleases and nuclease panels for scientific and research purposes; nucleases and nuclease panels derived from biotechnological processes for use in scientific and research purposes; assays and reagents for use in genetic research; nucleases and nuclease panels for use in genetic research
Enzyme preparations for medical purposes; enzymes for medical purposes; nucleases and nuclease panels for medical purposes; reagents for use in medical genetic testing; preparations for detecting genetic predispositions for medical purposes; pharmaceutical preparations for the treatment of genetic disorders; pharmaceutical preparations for the prevention of diseases or decisions caused by genetic predispositions; pharmaceutical preparations for editing of faulty genes; chemical preparations for pharmaceutical or medical purposes, namely, for editing of faulty genes; anti-cancer preparations; pharmaceutical products for the prevention and treatment of cancer; ocular pharmaceuticals; pharmaceutical preparations and substances for the treatment of genetic blood disorders
Testing, research, or development of pharmaceutical preparations for gene therapy; testing, research, selection, optimization or development of nucleases for gene targeting, gene editing, or gene therapy; DNA analysis services for scientific research purposes; genetic testing for scientific research purposes; scientific research in the field of genetics, gene editing and genetic engineering; providing medical and scientific research information in the fields of pharmaceuticals and genetics; scientific research consulting in the field of genetics; scientific research consulting in the field of gene editing; scientific research consulting in the field of selection and optimization of nucleases for gene editing and pharmaceutical development; scientific research in the field of selection and optimization of nucleases for gene editing and pharmaceutical development; pharmaceutical research services in the field of genetics and gene therapy, excluding production technologies; pharmaceutical research and development in the field of genetics and gene therapy, excluding production technologies; pharmaceutical products development in the field of genetics and gene therapy; pharmaceutical product evaluation in the field of genetics and gene therapy; pharmaceutical drug development services in the field of genetics and gene therapy, excluding production technologies; development of pharmaceutical preparations and medicines in the field of genetics and gene therapy; technical research in the field of pharmaceutical studies in the field of genetics and gene therapy, excluding production technologies; research and development in the pharmaceutical and biotechnology fields of genetics and gene therapy, excluding production technologies; testing of pharmaceuticals in the field of genetics and gene therapy; laboratory research services relating to pharmaceuticals in the field of genetics and gene therapy; conducting early evaluations in the field of new pharmaceuticals in the field of genetics and gene therapy; providing medical and scientific research information in the field of pharmaceuticals and clinical trials in the field of genetics and gene therapy; medical research services in the field of genetics and gene therapy; medical research services in the field of genetic blood disorders; medical research services in the field of genetic ocular disorders; scientific research for medical purposes in the field of gene editing and genetic disorders; scientific research for medical purposes in the field of nuclease and nuclease panel discovery and optimization for the development of gene-targeting pharmaceuticals